Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

ClinicalTrials.gov ID: NCT00294723

Public ClinicalTrials.gov record NCT00294723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Liraglutide Effect and Action in Diabetes (LEAD-3): Effect on Glycemic Control of Liraglutide Versus Glimepiride in Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in North America (the United States of America (USA) and Mexico). The trial is designed to evaluate the effects of treatment with liraglutide versus glimepiride in subjects with type 2 diabetes. The trial is a 52-week randomised, double-blind trial period plus a 52-week open-label extension (week 104) followed by an additional 156-week continued open-label extension. The total duration of the treatment period is planned to be 260 weeks (5 years).

Study identification

NCT ID
NCT00294723
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
746 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2006 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Nov 2008 (Actual)
Last update posted
Mar 7, 2017

2006 – 2008

United States locations

U.S. sites
102
U.S. states
31
U.S. cities
86
Facility City State ZIP Site status
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fullerton California 92835 —
Novo Nordisk Investigational Site Inglewood California 90301 —
Novo Nordisk Investigational Site Mission Viejo California 92691 —
Novo Nordisk Investigational Site Orange California 92869 —
Novo Nordisk Investigational Site Santa Barbara California 93105 —
Novo Nordisk Investigational Site Spring Valley California 91978 —
Novo Nordisk Investigational Site Vista California 92084 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Daytona Beach Florida 32117 —
Novo Nordisk Investigational Site Delray Beach Florida 33484 —
Novo Nordisk Investigational Site Jacksonville Florida 32205 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Longwood Florida 32779 —
Novo Nordisk Investigational Site Ocala Florida 34471 —
Novo Nordisk Investigational Site Saint Cloud Florida 34769 —
Novo Nordisk Investigational Site Athens Georgia 30606 —
Novo Nordisk Investigational Site Atlanta Georgia 30032 —
Novo Nordisk Investigational Site Atlanta Georgia 30034 —
Novo Nordisk Investigational Site Atlanta Georgia 30318 —
Novo Nordisk Investigational Site Atlanta Georgia 30339 —
Novo Nordisk Investigational Site Blue Ridge Georgia 30513 —
Novo Nordisk Investigational Site Columbus Georgia 31904 —
Novo Nordisk Investigational Site Marietta Georgia 30060 —
Novo Nordisk Investigational Site Powder Springs Georgia 30127 —
Novo Nordisk Investigational Site Tucker Georgia 30084 —
Novo Nordisk Investigational Site Honolulu Hawaii 96813 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Maywood Illinois 60153 —
Novo Nordisk Investigational Site Indianapolis Indiana 46202 —
Novo Nordisk Investigational Site Des Moines Iowa 50314 —
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Lexington Kentucky 40536 —
Novo Nordisk Investigational Site New Orleans Louisiana 70121 —
Novo Nordisk Investigational Site Baltimore Maryland 21218 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site Minneapolis Minnesota 55407 —
Novo Nordisk Investigational Site Saint Paul Minnesota 55108 —
Novo Nordisk Investigational Site Jackson Mississippi 39216 —
Novo Nordisk Investigational Site Tupelo Mississippi 38801 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017 —
Novo Nordisk Investigational Site City of Saint Peters Missouri 63376 —
Novo Nordisk Investigational Site St Louis Missouri 63104 —
Novo Nordisk Investigational Site St Louis Missouri 63110 —
Novo Nordisk Investigational Site Butte Montana 59701 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Reno Nevada 89502 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Plainsboro New Jersey 08536 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site Lewiston New York 14092 —
Novo Nordisk Investigational Site New York New York 10023 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site Staten Island New York 10301 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Asheville North Carolina 28803 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Durham North Carolina 27710 —
Novo Nordisk Investigational Site Greensboro North Carolina 27408 —
Novo Nordisk Investigational Site Cleveland Ohio 44195 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Mentor Ohio 44060 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104 —
Novo Nordisk Investigational Site Tulsa Oklahoma 74104 —
Novo Nordisk Investigational Site Bend Oregon 97710 —
Novo Nordisk Investigational Site Eugene Oregon 97401 —
Novo Nordisk Investigational Site Medford Oregon 97504-8491 —
Novo Nordisk Investigational Site Medford Oregon 97504 —
Novo Nordisk Investigational Site Lancaster Pennsylvania 17601 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site East Providence Rhode Island 02914 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Arlington Texas 76014 —
Novo Nordisk Investigational Site Corpus Christi Texas 78412 —
Novo Nordisk Investigational Site Dallas Texas 75208 —
Novo Nordisk Investigational Site Dallas Texas 75224 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Houston Texas 77024 —
Novo Nordisk Investigational Site Houston Texas 77025 —
Novo Nordisk Investigational Site Houston Texas 77030 —
Novo Nordisk Investigational Site Houston Texas 77074 —
Novo Nordisk Investigational Site Midland Texas 79707 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site Salt Lake City Utah 84132 —
Novo Nordisk Investigational Site Richmond Virginia 23249 —
Novo Nordisk Investigational Site Edmonds Washington 98026-7610 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Spokane Washington 99218 —
Novo Nordisk Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00294723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00294723 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →